Chemoinformaics analysis of 6,7-DIMETHOXY-2-(2-(4-METHOXYPHENYL)ETHYL)CHROMONE
| Molecular Weight | 340.375 | nRot | 6 |
| Heavy Atom Molecular Weight | 320.215 | nRig | 18 |
| Exact Molecular Weight | 340.131 | nRing | 3 |
| Solubility: LogS | -5.046 | nHRing | 1 |
| Solubility: LogP | 3.423 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 45 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 2 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 17 |
| nHA | 5 | APOL | 50.7459 |
| nHD | 0 | BPOL | 27.8761 |
| QED | 0.686 |
| Synth | 2.063 |
| Natural Product Likeliness | 0.421 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.999 |
| Pgp-sub | 0.092 |
| HIA | 0.003 |
| CACO-2 | -4.82 |
| MDCK | 0.000035 |
| BBB | 0.234 |
| PPB | 0.901895 |
| VDSS | 0.51 |
| FU | 0.0510289 |
| CYP1A2-inh | 0.744 |
| CYP1A2-sub | 0.974 |
| CYP2c19-inh | 0.924 |
| CYP2c19-sub | 0.852 |
| CYP2c9-inh | 0.862 |
| CYP2c9-sub | 0.93 |
| CYP2d6-inh | 0.146 |
| CYP2d6-sub | 0.947 |
| CYP3a4-inh | 0.821 |
| CYP3a4-sub | 0.817 |
| CL | 6.733 |
| T12 | 0.347 |
| hERG | 0.411 |
| Ames | 0.588 |
| ROA | 0.222 |
| SkinSen | 0.884 |
| Carcinogencity | 0.234 |
| EI | 0.159 |
| Respiratory | 0.455 |
| NR-Aromatase | 0.756 |
| Antiviral | Yes |
| Prediction | 0.816508 |